Product Information

RITALIN LA 10 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $12.0700 per EA under NDC 00078042405. Its NADAC has been published 405 times since Nov 28, 2013.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RITALIN LA 10 MG CAPSULE

methylphenidate hydrochloride
$12.0700per EA
DEA Schedule CII

Strength

10 mg/1

NDC

00078042405

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

9/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA021284

FDA Approved

6/5/2002

TE Code

AB1

On Market Since

6/5/2002

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for RITALIN LA 10 MG CAPSULE has been published 405 times since Nov 28, 2013, and over the history we have for it it has risen 136.3%. The table below summarizes its recorded NADAC range and movement.

Current price$12.0700 per EA
All-time high$12.1514 (Oct 16, 2024)
All-time low$5.1089 (Nov 28, 2013)
52-week high$12.0700
52-week low$12.0700
Median price$9.1175
Average price$9.2245
Largest weekly change+15.6% (Jan 17, 2024)
Weeks tracked405
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+26.2%

5Y

+26.2%

All

+136.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RITALIN LA 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RITALIN LA 10 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $12.0700 per EA (NDC 00078042405), effective Aug 19, 2026.

How has the price of RITALIN LA 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RITALIN LA 10 MG CAPSULE has risen 136.3%. It has been tracked across 405 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RITALIN LA 10 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RITALIN LA 10 MG CAPSULE has ranged from a low of $5.1089 (Nov 28, 2013) to a high of $12.1514 (Oct 16, 2024), with a median of $9.1175 per EA.

Are there cheaper alternatives to RITALIN LA 10 MG CAPSULE?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 10 MG CAP, is $1.2697 per EA — about 89% below RITALIN LA 10 MG CAPSULE.

Who manufactures RITALIN LA 10 MG CAPSULE?

RITALIN LA 10 MG CAPSULE (NDC 00078042405) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.